Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effect of Sleep Apnea on Pain After Dental Treatment (OSA-EndoPain)

6. mai 2026 oppdatert av: Ahmet AKAY, Harran University

Relationship Between Obstructive Sleep Apnea and Postoperative Pain After Endodontic Treatment

This observational study aims to investigate the effects of sleep quality and systemic health status on pain levels following endodontic treatment in adult patients. The primary goal is to determine how obstructive sleep apnea and common systemic conditions (diabetes and hypertension) influence postoperative dental pain.

The key questions it aims to answer are:

Does the severity of Obstructive Sleep Apnea (OSA) lead to higher postoperative pain scores after root canal treatment?

How does the presence of systemic diseases, such as diabetes and hypertension, affect pain perception compared to healthy individuals and OSA patients?

Comparison Groups:

Researchers will compare outcomes across three distinct cohorts:

OSA Group: Patients diagnosed with moderate-to-severe obstructive sleep apnea via polysomnography.

Systemic Disease Group: Patients with diagnosed systemic conditions, specifically diabetes and hypertension.

Control Group: Systemically healthy individuals without sleep disorders.

Participants will:

Undergo a polysomnography (PSG) evaluation to assess their sleep status.

Receive routine, standard-of-care endodontic treatment.

Record and report their pain intensity using the Visual Analog Scale (VAS) at specific intervals after the procedure.

Studieoversikt

Detaljert beskrivelse

Study Design and Power Analysis This observational study was designed to evaluate the interaction between Obstructive Sleep Apnea (OSA) and systemic diseases on postoperative pain following endodontic treatment. A power analysis was performed using G*Power 3.1 software with parameters f=0.40, α=0.05, and 80% power. While the analysis indicated a minimum of 66 participants, a total of 75 participants were targeted to account for a potential 15% dropout rate. The study was completed with 78 participants, maintaining and enhancing the required statistical power.

Participant Selection and Grouping

Patients aged 28 to 63 were enrolled based on their clinical status and divided into three groups:

Group 1 (n=24): Patients diagnosed with moderate (AHI 15-30) or severe (AHI >30) OSA via polysomnography (PSG) in an accredited sleep laboratory, who also presented with systemic diseases (Diabetes Mellitus and/or Hypertension).

Group 2 (n=24): Patients with diagnosed systemic diseases (Diabetes Mellitus and/or Hypertension) but without OSA.

Group 3 (n=30): Systemically healthy individuals without OSA (Control Group).

Exclusion criteria included the presence of periapical lesions on preoperative radiographs, chronic analgesic use, pregnancy, and failure to complete the study protocol. To minimize bias, the research team was blinded to the OSA classification process, and the data analyst was blinded during the statistical evaluation.

Standardized Endodontic Protocol To eliminate operator variability, all treatments were performed by a single experienced endodontist in a single session. Procedures were conducted under local anesthesia (2% lidocaine with 1:80,000 epinephrine) and rubber dam isolation. Root canal preparation was standardized using the VDW.ROTATE™ system up to a size 25.06 taper. The irrigation protocol included 5.25% NaOCl, 17% EDTA, and a final rinse with distilled water. Canals were obturated using the single-cone gutta-percha technique with AH Plus sealer.

Evaluation and Statistical Analysis Preoperative pain levels and postoperative pain at the 6th hour, 24th hour, and 7th day were recorded using a 10-point Visual Analog Scale (VAS) (0: no pain, 10: severe pain). The primary outcome was the difference in postoperative VAS scores between groups, while the secondary outcome was the duration of pain. Statistical analysis was performed using SPSS version 25. Due to non-normal distribution (confirmed via Kolmogorov-Smirnov test), the Kruskal-Wallis test with Bonferroni correction and the Mann-Whitney U test were utilized. The significance level was set at p < 0.05.

Studietype

Observasjonsmessig

Registrering (Faktiske)

78

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Outside of the US
      • Sanliurfa, Outside of the US, Tyrkia (Türkiye), 63300
        • Harran University Faculty of Dentristry,Departman of Endodonti

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

The study population consists of adult patients seeking endodontic treatment at the Harran University Faculty of Dentistry, Department of Endodontics. Participants are selected consecutively from individuals who have undergone polysomnography in an accredited sleep laboratory (for the OSA groups) and from patients with diagnosed systemic conditions such as diabetes and hypertension.

Beskrivelse

Inclusion Criteria:

  • Patients aged between 18 and 65 years.
  • Clinical requirement for endodontic (root canal) treatment.
  • Presence of a restorable tooth structure.
  • Diagnosis of moderate (AHI 15-30) or severe (AHI > 30) obstructive sleep apnea (OSA) confirmed by polysomnography, for relevant groups.
  • Patients with diagnosed systemic diseases (Diabetes Mellitus and/or Hypertension) or systemically healthy controls according to group allocation.

Exclusion Criteria:

  • Presence of periapical lesions identified during preoperative radiographic evaluation.
  • Chronic use of analgesics or long-term pain-management medications.
  • Pregnancy.
  • Failure to complete the established study protocol.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Grup 1 (OSA + Systemic Disease)
Patients diagnosed with moderate (AHI 15-30) or severe (AHI >30) Obstructive Sleep Apnea (OSA) via polysomnography, who also have systemic diseases such as Diabetes Mellitus and/or Hypertension.
Standardized single-session root canal treatment performed under rubber dam isolation and local anesthesia. Root canals are prepared using the VDW.ROTATE™ rotary system, irrigated with 5.25% NaOCl and 17% EDTA, and obturated with the single-cone technique using AH Plus sealer.
Grup 2 (Systemic Disease Only)
Patients diagnosed with systemic diseases such as Diabetes Mellitus and/or Hypertension, but who do not have Obstructive Sleep Apnea.
Standardized single-session root canal treatment performed under rubber dam isolation and local anesthesia. Root canals are prepared using the VDW.ROTATE™ rotary system, irrigated with 5.25% NaOCl and 17% EDTA, and obturated with the single-cone technique using AH Plus sealer.
Grup 3 (Control Group)
Systemically healthy individuals without any diagnosed systemic diseases or Obstructive Sleep Apnea.
Standardized single-session root canal treatment performed under rubber dam isolation and local anesthesia. Root canals are prepared using the VDW.ROTATE™ rotary system, irrigated with 5.25% NaOCl and 17% EDTA, and obturated with the single-cone technique using AH Plus sealer.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Postoperative Pain Intensity measured by Visual Analog Scale (VAS)
Tidsramme: Preoperative (baseline), 6 hours, 24 hours, and 7 days after the endodontic treatment.
Pain intensity is self-reported by patients using a 10-point Visual Analog Scale (VAS), where 0 represents "no pain" and 10 represents "severe pain".
Preoperative (baseline), 6 hours, 24 hours, and 7 days after the endodontic treatment.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Preoperative Baseline Pain Level
Tidsramme: Baseline (Preoperative)
Assessment of the participants' pain intensity before the start of the endodontic treatment using the 10-point Visual Analog Scale (VAS), where 0 represents "no pain" and 10 represents "severe pain". This measure is used to ensure baseline comparability between the groups.
Baseline (Preoperative)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

15. september 2025

Primær fullføring (Faktiske)

15. mars 2026

Studiet fullført (Faktiske)

30. mars 2026

Datoer for studieregistrering

Først innsendt

6. mai 2026

Først innsendt som oppfylte QC-kriteriene

6. mai 2026

Først lagt ut (Faktiske)

12. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

12. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

6. mai 2026

Sist bekreftet

1. mai 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Individual participant data (IPD) that are completely de-identified will be shared. This includes demographic information (age and sex), Apnea-Hypopnea Index (AHI) values, systemic health status (diabetes and hypertension status), and preoperative and postoperative Visual Analog Scale (VAS) pain scores. No personally identifying information of the participants will be disclosed to protect patient privacy.

IPD-delingstidsramme

The data will be available starting 6 months after journal publication and will remain accessible for up to 3 years.

Tilgangskriterier for IPD-deling

De-identified individual participant data can be requested by qualified researchers by emailing the corresponding author for academic and scientific purposes.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • ICF

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere